DANIELLE RAND: Open Payments
NPI 1588916225 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 106 payments from 15 companies in 2025. Trend: 2023 $3,822 · 2024 $1,542 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $196 |
| Merck Sharp & Dohme LLC | 9 | $178 |
| E.R. Squibb & Sons, L.L.C. | 16 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $162 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 16 | $150 |
| PFIZER INC. | 11 | $138 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Azurity Pharmaceuticals, Inc. | 3 | $53 |
| Tactile Systems Technology Inc | 2 | $41 |
Products named: ELIQUIS, Wegovy, Kerendia, LifeVest, VERQUVO, LEQVIO, EDARBI, CAMZYOS.
Industry payments across PA — which companies pay providers there.
